Metraipolis › archive › dc_c311840f2dbe
Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China — Europe PMC PMID:41394150
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41394150
- DOI
- 10.3389/fphar.2025.1684966
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:36:12.463Z
- SHA-256 of the archived text
9c91f0f39a14e9c6ca5a990f98775eaeabf0cf54c3c7125ba6f632d378a421ed- Stable URL of this page
https://metraipolis.com/documento/dc_c311840f2dbe
How to cite
Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China — Europe PMC PMID:41394150 — Europe PMC (en), https://europepmc.org/article/MED/41394150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c311840f2dbe (Metraipolis archive dc_c311840f2dbe, sha256 9c91f0f39a14e9c6ca5a990f98775eaeabf0cf54c3c7125ba6f632d378a421ed)
BibTeX
@misc{dcc311840f2dbe,
title = {Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China — Europe PMC PMID:41394150},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41394150},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c311840f2dbe; sha256 9c91f0f39a14e9c6ca5a990f98775eaeabf0cf54c3c7125ba6f632d378a421ed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41394150. Agents can read the archived copy with the MCP tool read_document.